Racine A - Search Results

1

Bayesian models for subgroup analysis in clinical trials.

Jones HE, Ohlssen DI, Neuenschwander B, Racine A, Branson M. Jones HE, et al. Among authors: racine a. Clin Trials. 2011 Apr;8(2):129-43. doi: 10.1177/1740774510396933. Epub 2011 Jan 31. Clin Trials. 2011. PMID: 21282293

2

A flexible Bayesian approach for modeling monotonic dose-response relationships in drug development trials.

Ohlssen D, Racine A. Ohlssen D, et al. Among authors: racine a. J Biopharm Stat. 2015;25(1):137-56. doi: 10.1080/10543406.2014.919931. J Biopharm Stat. 2015. PMID: 24836192

3

Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts.

Bretz F, Schmidli H, König F, Racine A, Maurer W. Bretz F, et al. Among authors: racine a. Biom J. 2006 Aug;48(4):623-34. doi: 10.1002/bimj.200510232. Biom J. 2006. PMID: 16972714

4

Designing a non-inferiority study in kidney transplantation: a case study.

Witte S, Schmidli H, O'Hagan A, Racine A. Witte S, et al. Among authors: racine a. Pharm Stat. 2011 Sep-Oct;10(5):427-32. doi: 10.1002/pst.511. Epub 2011 Sep 16. Pharm Stat. 2011. PMID: 21928323

5

Dose-response analysis of ranibizumab as-needed regimens for visual improvement in patients with diabetic macular edema using a modelling approach.

Xiong Y, Pigeolet E, Mulyukov Z, Margaron P, Racine A, Clemens A. Xiong Y, et al. Among authors: racine a. Contemp Clin Trials. 2019 May;80:34-39. doi: 10.1016/j.cct.2019.03.008. Epub 2019 Mar 21. Contemp Clin Trials. 2019. PMID: 30904595 Free article. Clinical Trial.

6

Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations.

Schmidli H, Bretz F, Racine A, Maurer W. Schmidli H, et al. Among authors: racine a. Biom J. 2006 Aug;48(4):635-43. doi: 10.1002/bimj.200510231. Biom J. 2006. PMID: 16972715

7

Neovascular Age-Related Macular Degeneration: A Visual Acuity Model of Natural Disease Progression and Ranibizumab Treatment Effect.

Mulyukov Z, Weber S, Pigeolet E, Clemens A, Lehr T, Racine A. Mulyukov Z, et al. Among authors: racine a. CPT Pharmacometrics Syst Pharmacol. 2018 Oct;7(10):660-669. doi: 10.1002/psp4.12322. Epub 2018 Aug 15. CPT Pharmacometrics Syst Pharmacol. 2018. PMID: 30043524 Free PMC article.

8

Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group.

Judson I, Ma P, Peng B, Verweij J, Racine A, di Paola ED, van Glabbeke M, Dimitrijevic S, Scurr M, Dumez H, van Oosterom A. Judson I, et al. Among authors: racine a. Cancer Chemother Pharmacol. 2005 Apr;55(4):379-386. doi: 10.1007/s00280-004-0876-0. Epub 2004 Dec 9. Cancer Chemother Pharmacol. 2005. PMID: 15592836

9

Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.

Demetri GD, Wang Y, Wehrle E, Racine A, Nikolova Z, Blanke CD, Joensuu H, von Mehren M. Demetri GD, et al. Among authors: racine a. J Clin Oncol. 2009 Jul 1;27(19):3141-7. doi: 10.1200/JCO.2008.20.4818. Epub 2009 May 18. J Clin Oncol. 2009. PMID: 19451435 Clinical Trial.

10

Pretreatment with aldosterone or corticosterone blocks the memory-enhancing effects of nimodipine, captopril, CGP 37,849, and strychnine in mice.

Mondadori C, Gentsch C, Hengerer B, Ducret T, Borkowski J, Racine A, Lederer R, Haeusler A. Mondadori C, et al. Among authors: racine a. Psychopharmacology (Berl). 1992;109(4):383-9. doi: 10.1007/BF02247712. Psychopharmacology (Berl). 1992. PMID: 1365851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters